These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 6186411)
1. Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal. Ellims PH Cancer Chemother Pharmacol; 1982 Dec; 10(1):1-6. PubMed ID: 6186411 [TBL] [Abstract][Full Text] [Related]
2. An overview of thymidine. Martin DS; Stolfi RL; Sawyer RC; Nayak R; Spiegelman S; Young CW; Woodcock T Cancer; 1980 Mar; 45(5 Suppl):1117-28. PubMed ID: 6986974 [TBL] [Abstract][Full Text] [Related]
6. Role of thymidine in biochemical modulation: a review. O'Dwyer PJ; King SA; Hoth DF; Leyland-Jones B Cancer Res; 1987 Aug; 47(15):3911-9. PubMed ID: 3300957 [TBL] [Abstract][Full Text] [Related]
7. [Selective tumour chemotherapy using oncobiograms (author's transl)]. Volm M; Kaufmann M; Wayss K; Goerttler K; Mattern J Dtsch Med Wochenschr; 1974 Jan; 99(2):38-43. PubMed ID: 4129485 [No Abstract] [Full Text] [Related]
8. 3-Deazauridine (NSC 126849): an interesting modulator of biochemical response. Moriconi WJ; Slavik M; Taylor S Invest New Drugs; 1986; 4(1):67-84. PubMed ID: 2422137 [TBL] [Abstract][Full Text] [Related]
10. Different effects of epigenetic modifiers on the cytotoxicity induced by 5-fluorouracil, irinotecan or oxaliplatin in colon cancer cells. Ikehata M; Ogawa M; Yamada Y; Tanaka S; Ueda K; Iwakawa S Biol Pharm Bull; 2014; 37(1):67-73. PubMed ID: 24172061 [TBL] [Abstract][Full Text] [Related]
11. Increased IFNγ Li X; Zhang Y; Chen M; Mei Q; Liu Y; Feng K; Jia H; Dong L; Shi L; Liu L; Nie J; Han W Clin Cancer Res; 2017 Oct; 23(20):6031-6043. PubMed ID: 28706011 [No Abstract] [Full Text] [Related]
12. Activity of differentiation-inducing agents and conventional drugs in head and neck cancer xenografts. van Dongen G; Braakhuis BJ; Bagnay M; Leyva A; Snow GB Acta Otolaryngol; 1988; 105(5-6):488-93. PubMed ID: 2456664 [TBL] [Abstract][Full Text] [Related]
13. Nude mouse models as predictors of chemotherapy in man: thymidine and pyrimidines. Goldin A; Wolpert-Defilippes MK Bull Cancer; 1979; 66(1):61-6. PubMed ID: 420948 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring of antimetabolic cytotoxic drugs. Lennard L Br J Clin Pharmacol; 1999 Feb; 47(2):131-43. PubMed ID: 10190647 [TBL] [Abstract][Full Text] [Related]
15. Is there a role for thymidine in cancer chemotherapy? Schornagel JH; Leyva A; Pinedo HM Cancer Treat Rev; 1982 Dec; 9(4):331-52. PubMed ID: 6762925 [No Abstract] [Full Text] [Related]
16. Decitabine. Daskalakis M; Blagitko-Dorfs N; Hackanson B Recent Results Cancer Res; 2010; 184():131-57. PubMed ID: 20072836 [TBL] [Abstract][Full Text] [Related]
18. Phase I study on 5-aza-2'-deoxycytidine in children with acute leukemia. Rivard GE; Momparler RL; Demers J; Benoit P; Raymond R; Lin K; Momparler LF Leuk Res; 1981; 5(6):453-62. PubMed ID: 6173545 [No Abstract] [Full Text] [Related]
20. The euphoria of hypomethylating agents in MDS and AML: is it justified? Sekeres MA Best Pract Res Clin Haematol; 2013 Sep; 26(3):275-8. PubMed ID: 24309530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]